{"component": "clause", "props": {"groups": [{"size": 3, "snippet": "Targets principally involved in [**], including, without limitation, [**], but excluding Targets of [**]. Inflammatory Disease: Targets principally involved in [**]. Such disorders include, without limitation, those [**], including [**], but excluding Targets of [**].", "samples": [{"hash": "jEVVmoQjUH3", "uri": "/contracts/jEVVmoQjUH3#hematology", "label": "License and Collaboration Agreement (Arrowhead Research Corp)", "score": 22.9657768652, "published": true}, {"hash": "8Sk3Ami7WJK", "uri": "/contracts/8Sk3Ami7WJK#hematology", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.0, "published": true}, {"hash": "2E59iC5c6EH", "uri": "/contracts/2E59iC5c6EH#hematology", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "snippet_links": [{"key": "without-limitation", "type": "clause", "offset": [49, 67]}, {"key": "but-excluding", "type": "clause", "offset": [75, 88]}, {"key": "inflammatory-disease", "type": "definition", "offset": [106, 126]}], "hash": "f67748697c2b6b995e6e9f518186cd21", "id": 2}, {"size": 4, "snippet": "Hematology testing will be performed on Day 1 and at Month 6. The following tests will be performed: Hematology: \u00b7 Hemoglobin \u00b7 Hematocrit \u00b7 WBC count with differential in absolute counts \u00b7 RBC count \u00b7 Mean corpuscular volume (MCV) \u00b7 Mean corpuscular hemoglobin concentration (MCHC) \u00b7 Mean corpuscular hemoglobin (MCH) \u00b7 Platelet count", "samples": [{"hash": "kY1LKEjtATo", "uri": "/contracts/kY1LKEjtATo#hematology", "label": "Clinical Trial Services Agreement (Radius Health, Inc.)", "score": 23.1861738535, "published": true}, {"hash": "eUgAqC1R4st", "uri": "/contracts/eUgAqC1R4st#hematology", "label": "Clinical Trial Services Agreement (Radius Health, Inc.)", "score": 22.9452429843, "published": true}], "snippet_links": [{"key": "day-1", "type": "definition", "offset": [40, 45]}], "hash": "c74fc7060d49de0fe6821dd5c7237538", "id": 1}, {"size": 2, "snippet": "Hematology studies will be evaluated at screening (Visit 1), Visit 10 (week 28) and end of treatment (Visit 17 or study withdrawal) for hemoglobin, hematocrit, red blood cell count (RBC), total white blood cell count (WBC), WBC differential (neutrophils, lymphocytes, monocytes, eosinophils, basophils) and platelet count.", "samples": [{"hash": "gWR6eqkVEur", "uri": "/contracts/gWR6eqkVEur#hematology", "label": "Master Services Agreement (Vivus Inc)", "score": 24.3483915127, "published": true}], "snippet_links": [{"key": "end-of-treatment", "type": "clause", "offset": [84, 100]}], "hash": "420f460c4c102aa174438c2bf9dfb820", "id": 3}, {"size": 2, "snippet": "Samples will be collected for the following hematology assessments as indicated in Table 3: hematocrit, hemoglobin, red blood cell (RBC) count, white blood cell (WBC) count, neutrophils, bands (if detected), lymphocytes, monocytes, basophils (if detected), eosinophils (if detected), absolute platelet count, mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), and mean corpuscular hemoglobin concentration (MCHC).", "samples": [{"hash": "9hXJczMiPK", "uri": "/contracts/9hXJczMiPK#hematology", "label": "Investigator's Agreement", "score": 24.3990417522, "published": true}], "snippet_links": [{"key": "as-indicated", "type": "definition", "offset": [67, 79]}, {"key": "table-3", "type": "clause", "offset": [83, 90]}], "hash": "fd2b6d270f85da7a7f884d168e873757", "id": 4}, {"size": 1, "snippet": "Hematology tests will include complete blood count, including red blood cells, white blood cells with differentiation, hemoglobin, hematocrit, reticulocytes, and platelets. The coagulation panel will include activated partial thromboplastin time, prothrombin time, and international normalized ratio.", "samples": [{"hash": "kzY1lneEJGo", "uri": "/contracts/kzY1lneEJGo#hematology", "label": "Investigator Agreement", "score": 29.8610137248, "published": true}], "snippet_links": [], "hash": "c6729913295d3f5f539f20ded0306436", "id": 5}, {"size": 1, "snippet": "The following hematology tests will be performed: \u2022 hemoglobin \u2022 hematocrit \u2022 platelet count \u2022 absolute neutrophil count (ANC) \u2022 white blood cell (WBC) count and differential count \u2014 polymorphonuclear leukocytes (neutrophils) \u2014 lymphocytes \u2014 eosinophils \u2014 monocytes \u2014 basophils \u2014 metamyelocytes", "samples": [{"hash": "b97cChpRyTx", "uri": "/contracts/b97cChpRyTx#hematology", "label": "Investigator Agreement", "score": 25.4465006512, "published": true}], "snippet_links": [], "hash": "1bb15e198a7cb78e797e5c2cd6c64128", "id": 6}, {"size": 1, "snippet": "\u200c Blood will be obtained as noted in the Schedule of Events and sent to each site\u2019s clinical hematology lab for a complete blood count with differential (i.e., hemoglobin, hematocrit, red blood cell count, white blood cell count, white blood cell differential, and platelet count).", "samples": [{"hash": "j8hSCL56ZJD", "uri": "/contracts/j8hSCL56ZJD#hematology", "label": "Protocol Agreement", "score": 29.7688040603, "published": true}], "snippet_links": [{"key": "schedule-of-events", "type": "clause", "offset": [41, 59]}, {"key": "complete-blood-count-with-differential", "type": "definition", "offset": [114, 152]}], "hash": "1fe8db99007c6d9a441926b9d4fd90e9", "id": 7}, {"size": 1, "snippet": "Blood will be obtained as noted in the Schedule of Events and sent to each site\u2019s clinical hematology lab for a complete blood count (hemoglobin, hematocrit, red blood cell count, white blood cell count, white blood cell differential, and platelet count). If values are abnormal and clinically significant at Visit 4, a sample will be collected and these parameters re-evaluated at a follow-up visit two weeks later.", "samples": [{"hash": "5bD4xgFO1IC", "uri": "/contracts/5bD4xgFO1IC#hematology", "label": "Protocol Agreement", "score": 32.3735844753, "published": true}], "snippet_links": [{"key": "schedule-of-events", "type": "clause", "offset": [39, 57]}, {"key": "a-sample", "type": "definition", "offset": [318, 326]}, {"key": "two-weeks", "type": "clause", "offset": [400, 409]}], "hash": "01feb9cb7c8156ec4745a2c74cef2fe9", "id": 8}, {"size": 1, "snippet": "Diseases of the bone marrow or of cells originating in [**] and excluding hematologic diseases of [**]. Hepatic: Diseases of the [**], including, [**] and excluding hepatic diseases of [**]. Inflammatory Disease: [**], including those [**], including [**] and excluding inflammatory diseases of [**]. Musculoskeletal Disease: Diseases of the muscles, ligaments or bone, including, [**] and excluding musculoskeletal diseases of [**]. Neurodegenerative Disease: [**] involving [**], including [**] and excluding neurodegenerative diseases of [**].", "samples": [{"hash": "absHN1ffB62", "uri": "/contracts/absHN1ffB62#hematology", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "snippet_links": [{"key": "bone-marrow", "type": "definition", "offset": [16, 27]}, {"key": "inflammatory-disease", "type": "definition", "offset": [191, 211]}], "hash": "c7de3a0ff47b84fa8e2258d742e13ea7", "id": 9}, {"size": 1, "snippet": "Blood will be obtained and sent to each site\u2019s clinical hematology lab for a complete blood count (hemoglobin, hematocrit, red blood cell count, white blood cell count, white blood cell differential, and platelet count).", "samples": [{"hash": "3OTFPPt8NOX", "uri": "/contracts/3OTFPPt8NOX#hematology", "label": "Protocol Agreement", "score": 25.7175000417, "published": true}], "snippet_links": [], "hash": "3f66a34f6343d3ed3e2507d4e97b943e", "id": 10}], "next_curs": "ClMSTWoVc35sYXdpbnNpZGVyY29udHJhY3Rzci8LEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhNoZW1hdG9sb2d5IzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"size": 17, "parents": [["clinical-laboratory-measurements", "Clinical Laboratory Measurements"], ["prohibited-medications", "Prohibited Medications"], ["clinical-procedures-assessments", "Clinical Procedures Assessments"], ["conflicts-between-agreements", "CONFLICTS BETWEEN AGREEMENTS"], ["treatment-of", "Treatment of **"]], "title": "Hematology", "children": [["hematology-joint-venture", "Hematology Joint Venture"], ["purchase-iris-securities", "Purchase IRIS Securities"]], "id": "hematology", "related": [["diagnostic", "Diagnostic", "Diagnostic"], ["therapies", "Therapies", "Therapies"], ["speech-therapy", "Speech Therapy", "Speech Therapy"], ["screening", "Screening", "Screening"], ["hepatitis-b-vaccine", "Hepatitis B Vaccine", "Hepatitis B Vaccine"]], "related_snippets": [], "updated": "2025-07-07T12:37:54+00:00", "also_ask": ["What are the essential elements to include in a Hematology clause to ensure comprehensive coverage?", "How can parties strategically negotiate the scope of Hematology obligations or disclosures?", "What are the most common legal risks or ambiguities associated with Hematology clauses?", "How do Hematology clauses differ across jurisdictions or industry standards?", "What factors determine the enforceability of Hematology clauses in court?"], "drafting_tip": "Specify the hematology services covered to prevent scope disputes; define key terms to avoid ambiguity; outline reporting requirements to ensure compliance.", "explanation": "The Hematology clause defines the responsibilities and procedures related to blood analysis and related laboratory testing within the scope of an agreement. It typically outlines which party is responsible for conducting hematology tests, the standards or protocols to be followed, and how results are to be reported or used. For example, in a clinical trial agreement, this clause may specify that the sponsor will cover the costs of routine blood tests for participants and ensure that results are shared with investigators in a timely manner. The core function of this clause is to ensure clarity and accountability regarding hematology testing, thereby minimizing misunderstandings and ensuring that all parties are aware of their obligations."}, "json": true, "cursor": ""}}